ArticleHaematologica2023

Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.

Alan S Wayne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.